Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | EP Lab

May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of electrophys ...

Home May 20, 2020
Home
News | Atrial Fibrillation

May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the ...

Home May 19, 2020
Home
News | Atrial Fibrillation

May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking ...

Home May 19, 2020
Home
News | Atrial Fibrillation

May 13, 2020 — The PRECEPT study testing the use of the Biosense Webster Thermocool Smarttouch SF Catheter for the ...

Home May 13, 2020
Home
News | EP Lab

May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc. HeartLight ...

Home May 12, 2020
Home
News | Atrial Fibrillation

May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of ...

Home May 08, 2020
Home
News | Atrial Fibrillation

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety ...

Home May 08, 2020
Home
News | Atrial Fibrillation

May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation (AF ...

Home May 08, 2020
Home
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20
Feature | Ablation Systems

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
News | Wearables

May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHR ...

Home May 08, 2020
Home
News | ECG Wireless Remote Access

May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor ...

Home May 04, 2020
Home
News | Atrial Fibrillation

March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing ...

Home March 29, 2020
Home
OTC ECG devices
Feature | ECG

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

Home March 11, 2020
Home
Videos | Structural Heart

Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant ...

Home February 27, 2020
Home
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 
Feature | ECG

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...

Home February 19, 2020
Home
Subscribe Now